Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission
ClinicalTrials.gov study NCT02302846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00744757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
ClinicalTrials.gov study NCT03433781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03094637. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03399773. IPD Sharing: NO. Countries: 1. Publications: 0.
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00462605. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
ClinicalTrials.gov study NCT01083706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib Study for Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00977548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00475020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01822691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01272245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01542684. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aflibercept in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00509249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis
ClinicalTrials.gov study NCT03718143. IPD Sharing: YES. Countries: 1. Publications: 0.
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
ClinicalTrials.gov study NCT02121418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents
ClinicalTrials.gov study NCT01246076. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
ClinicalTrials.gov study NCT02000154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LBH589 in Refractory Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00594230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00398047. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
ClinicalTrials.gov study NCT01191749. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.